Research
Investing in research, focused on patients
We invest in outstanding scientific research and innovative research models to expedite promising therapies to patients.
This is a pivotal time in the history of the amyloidosis, with the approval of three drugs for ATTR in 2019 and a number of new therapies on the horizon. Increasing the level of support is essential for research in these underserved diseases. Researchers, clinicians and partners in the biotech and pharmaceutical industries are working on the development of therapies that are changing the landscape and improving the outlook for patients.
The Amyloidosis Foundation is committed to serving patient needs by supporting research and providing annual grants for junior research scientists whose research targets the challenges in the field of amyloidosis.
The Amyloidosis Foundation is committed to serving patient needs by supporting research and providing annual grants for junior research scientists whose research targets the challenges in the field of amyloidosis.
Grant Programs
For over a decade, the Amyloidosis Foundation grant program has supported outstanding research in all forms of systemic amyloidosis. Through our research program, we encourage, promote and invest in the medical study and exploration of amyloidosis diseases.
Research Grants
Candidates will have completed their doctoral studies or clinical fellowship within ten years prior to application. Grants are awarded for one year according to the award conditions and reporting guidelines.
On request, a second year of funding will be considered, pending a review of the research progress and as foundation funding permits.
Grant Programs
Research Grants
Candidates will have completed their doctoral studies or clinical fellowship within ten years prior to application. Grants are awarded for one year according to the award conditions and reporting guidelines.
On request, a second year of funding will be considered, pending a review of the research progress and as foundation funding permits.
Grant Programs
Travel Grants
The foundation is dedicated to encouraging young scientists that show an interest in amyloidosis research, by providing travel grants to physicians and researchers who have completed their medical doctorate or fellowship within the past 10 years. These grants enable participation in the bi-annual International Amyloidosis Symposium.
2024 Junior Researcher Travel Award ApplicationGrant Rounds
The Amyloidosis Foundation has a very successful Grand Rounds program, as part of our commitment to raise awareness of the amyloidosis diseases. We will sponsor an expert in amyloidosis to speak to doctors and medical staff regarding the diagnostic tools, clinical protocols and treatment therapies that are currently available.
Our speakers are among the most knowledgeable specialists in the U.S. and are involved in amyloidosis research and patient care. The Amyloidosis Foundation will arrange for the speaker and will cover all travel expenses and honoraria.
Physicians who are available for our Grand Rounds Program include:
Our speakers are among the most knowledgeable specialists in the U.S. and are involved in amyloidosis research and patient care. The Amyloidosis Foundation will arrange for the speaker and will cover all travel expenses and honoraria.
Physicians who are available for our Grand Rounds Program include:
- Adam Cohen, MD – University of Pennsylvania – Hematology
- Raymond Comenzo, MD – Tufts Medical Center – Hematology
- Rodney Falk, MD – Brigham & Women’s Hospital – Cardiology
- Morie Gertz, MD – Mayo Clinic, Rochester – Hematology
- Martha Grogan, MD – Mayo Clinic, Rochester – Cardiology
- James Hoffman, MD – University of Miami – Hematology
- Robert Kyle, MD – Mayo Clinic, Rochester – Hematology
- Heather Landau, MD – Memorial Sloan-Kettering – Hematology
- Mathew Maurer, MD – Columbia University Medical Ctr. – Cardiology
- Raymond Migrino MD – Phoenix Veterans Administration – Cardiology
- Vaishali Sanchorawala, MD – Boston University Amyloid Program – Hematology
- Adam Segal, MD – Brigham & Women’s Hospital – Nephrology
- Marc Semigran, MD – Massachusetts General – Cardiology
- Brendan Weiss, MD – University of Pennsylvania – Hematology
- Ron Witteles, MD – Stanford University Medical Center – Cardiology
- Jeffrey Zonder, MD – Karmanos Cancer Center – Hematology
If you have an interest in having one of our speakers give Grand Rounds on amyloidosis at your medical facility, please contact us:
(248)922-9610[email protected]